ASTHAstrana Health, Inc.

$37.58+35% 1Y

The financials

Astrana Health, Inc. by the numbers

Astrana Health, Inc. (ASTH) reported revenue of $973M in Q2 2026 (quarter ended Jun 30, 2026), up 49% from the same quarter a year earlier. That came with a gross margin of 11% and net income of $20M (2.0% of revenue). For the full year FY2025, revenue was $3.18B (+56% year on year) and net income $22M. Its largest product in Q2 2026 was Health Care Capitation at $906M, 93% of the disclosed total, well ahead of Health Care Patient Service at 2.4%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.

Astrana Health, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$973M$655M+49%
Gross profit$104M$78M+33%
Operating income$34M$20M+69%
Net income$20M$9.4M+109%
Diluted EPS$0.40$0.19+111%
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Health Care Capitation$906M93%
Health Care Patient Service$23M2.4%
Health Care Other$22M2.2%
Management Service$13M1.4%
Product And Service Other$8.7M0.9%

Business segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $972.5M (+0.77%)
Management Service grew +413% year on yearHealth Care Patient Service +29% year on year
  • Health Care Capitation$905.8Mquarter on quarter +1.4%year on year +47%
  • Health Care Patient Service$23.0Mquarter on quarter -39%year on year +29%
  • Health Care Other$21.8Mquarter on quarter +75%year on year +42%
  • Management Service$13.2Mquarter on quarter -16%year on year +413%
  • Product And Service Other$8.7Mquarter on quarter +41%year on year +80%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed Aug 10, 2026, SEC EDGAR